Search

everythinglearnresearchcommunity

for

Search:↓

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

The role of γδT-cells in causing alopecia areata remains unclear.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

ALDOA levels drop in hair cells during hair loss.

Personalized homeopathic treatment may help manage alopecia areata.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Nanoparticles can improve skin treatments by better targeting hair follicles, but more research is needed for advancement.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Sebaceous glands in male pattern hair loss patients have more lobules and might cause early hair growth phase shifts.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

A dog with complete hair loss regrew most hair after treatment, with no relapse after stopping treatment.

Hair loss treatment caused more hair loss in a man.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Early detection, prevention, and proper management can reduce TB-IRIS complications and deaths in HIV patients.

A girl with severe hair loss saw hair regrowth after using cannabis.

A man had both alopecia areata and lichen planus, which is uncommon.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Autoimmune and inflammatory processes are involved in both scarring and non-scarring types of hair loss.

Auto-portraits help evaluate scalp hair.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.